EMD Serono Competitors and Similar CompaniesClear all
EMD Serono's competitors and similar companies include Biogen, Teva, Hikma Pharmaceuticals and Sun Pharma.
 EMD Serono EMD Serono, the North America biopharma business of Merck KGaA, Darmstadt, Germany. Committed to transforming lives. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products. |  Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. | ||
Founding Date | Founding Date N/A | Founding Date 1978 | Founding Date 1901 | Founding Date 1978 | Founding Date 1983 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Rockland, US HQ Mississauga, CA Billerica, US | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations HQ | Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more |
Employees | Employees 1,852 | Employees 7,605 | Employees 29,780 | Employees 9,500 | Employees 43,000 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) N/A | Valuation ($) 5.6 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $3.3b (FY, 2025) | Revenue (est.) ₹582.2b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods $1.7b (FY, 2025) | Cost of goods ₹115.4b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit $1.7b (FY, 2025) | Gross profit ₹488.9b (FY, 2026) |
Net income | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A | Net income $407m (FY, 2025) | Net income ₹115.6b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyHikma Pharmaceuticals
HQ
London, GB
Employees
9,500
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
View companySun Pharma
HQ
Mumbai, IN
Employees
43,000
Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View company